Media Summary: Biotech investors and oncology researchers: 90% of new drug discoveries fail in the clinic, costing the industry billions in lost capital and years of development time. RADR®, or Response Algorithm for Drug Positioning & Rescue, is
Lantern Pharma Nasdaq Ltrn Is - Detailed Analysis & Overview
Biotech investors and oncology researchers: 90% of new drug discoveries fail in the clinic, costing the industry billions in lost capital and years of development time. RADR®, or Response Algorithm for Drug Positioning & Rescue, is This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from 0:00 Introduction 7:40 4th quarter 2024 highlights 29:30 Financial updates 33:45